Comprehensive COVID-19 Slideset: Treatments

Comprehensive slideset updated regularly to include the latest data and guidance on treatments for COVID-19, including authorized and investigational agents.
Arthur Kim, MD
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Kristen Marks, MD
Renslow Sherer, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.92 MB
Released: August 10, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Expert faculty provide a comprehensive overview of current landscape of outpatient COVID-19 management strategies, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Renslow Sherer, MD person default Trinh P. Vu, PharmD, BCIDP Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 22, 2022 Expired: November 21, 2023

Dr Gregory Huhn discusses new COVID-19 data from IDWeek 2022 on severe breakthrough infection risk and antiviral treatment, from Clinical Care Options (CCO)

Gregory Huhn, MD, MPHTM Released: November 17, 2022

Dr Cristina Mussini discusses new data from IDWeek 2022 on COVID-19 prophylaxis, treatment, and opportunistic infections, from Clinical Care Options (CCO)

Cristina Mussini, MD Released: November 17, 2022

Dr Alicia Lichvar: importance of COVID-19 prevention in patients with immunocompromise, from Clinical Care Options (CCO)

person default Alicia Lichvar, PharmD, MS, BCPS, BCTXP Released: November 17, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings